AI Image
FDA Announces New Nationwide Blood Pressure Medication Recall
Yahoo • • health
Key Points:
- Inventia Healthcare has issued two Class II recalls for certain lots of chlorthalidone tablets, a medication used to treat high blood pressure, due to failed dissolution specifications that may reduce the drug's effectiveness.
- The September 3 recall affects over 13,000 bottles of 25 mg chlorthalidone tablets, specifically batch RISA24002 with an expiration date of April 2027.
- A Class II recall indicates that exposure to the affected medication could cause temporary or medically reversible health issues, but serious problems are unlikely.
- Patients with the recalled medication should not stop taking it without consulting their healthcare provider and should report any adverse symptoms immediately.
- Consumers are advised to check their prescription labels carefully and contact their pharmacist if they are uncertain whether their medication is part of the recall.
